Selective vulnerability of hippocampal NAAGergic neurons in experimental temporal lobe epilepsy

Brain Research

Volumn 1144, Issue 1, 2007, Pages 219-230

  Pacheco Otalora, Luis F ^a   Moffett, John R ^b   Garrido Sanabria, Emilio R ^a,c  

^a UNIVERSITY OF TEXAS AT BROWNSVILLE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c The Center for Biomedical Studies   (United States)

Author keywords

Interneuron; NAAG; Pilocarpine; Seizures; Status epilepticus

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; METABOTROPIC RECEPTOR; N ACETYLASPARTYLGLUTAMIC ACID; PILOCARPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL LOSS; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RAT; SUBICULUM; TEMPORAL LOBE EPILEPSY;

ANIMALS; CELL COUNT; CELL SURVIVAL; DIPEPTIDES; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; ISOENZYMES; MALE; NEURONS; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

RATTUS;

EID: 33947331893     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.112     Document Type: Article

References (72)

1. Anderson K.J., Monaghan D.T., Cangro C.B., Namboodiri M.A., Neale J.H., and Cotman C.W. Localization of N-acetylaspartylglutamate-like immunoreactivity in selected areas of the rat brain. Neurosci. Lett. 72 1 (1986) 14-20
2. Andre V., Marescaux C., Nehlig A., and Fritschy J.M. Alterations of hippocampal GABAergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 11 4 (2001) 452-468
3. Bacich D.J., Ramadan E., O'Keefe D.S., Bukhari N., Wegorzewska I., Ojeifo O., Olszewski R., Wrenn C.C., Bzdega T., Wroblewska B., Heston W.D., and Neale J.H. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate. J. Neurochem. 83 1 (2002) 20-29
4. Berger U.V., Luthi-Carter R., Passani L.A., Elkabes S., Black I., Konradi C., and Coyle J.T. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J. Comp. Neurol. 415 1 (1999) 52-64
5. Bergeron R., Coyle J.T., Tsai G., and Greene R.W. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology 30 1 (2005) 7-16
6. Blakely R.D., Robinson M.B., Thompson R.C., and Coyle J.T. Hydrolysis of the brain dipeptide N-acetyl-l-aspartyl-l-glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N-acetylated-alpha-linked acidic dipeptidase activity. J. Neurochem. 50 4 (1988) 1200-1209
7. Bzdega T., Crowe S.L., Ramadan E.R., Sciarretta K.H., Olszewski R.T., Ojeifo O.A., Rafalski V.A., Wroblewska B., and Neale J.H. The cloning and characterization of a second brain enzyme with NAAG peptidase activity. J. Neurochem. 89 3 (2004) 627-635
8. Cavalheiro E.A. The pilocarpine model of epilepsy. Ital. J. Neurol. Sci. 16 1-2 (1995) 33-37
9. Cossart R., Bernard C., and Ben-Ari Y. Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci. 28 2 (2005) 108-115
10. Coyle J.T. The nagging question of the function of N-acetylaspartylglutamate. Neurobiol. Dis. 4 3-4 (1997) 231-238
11. Curatolo A. Isolation and identification of a new dipeptide acetylconjugate of nerve tissue. N-acetyl-aspartyl-glutamic acid. Boll. Soc. Ital. Biol. Sper. 40 24 (1964) 2138-2141
12. Curatolo A., D'Arcangelo P., Lino A., and Brancati A. Distribution of N-acetyl-aspartyl-glutamic acid in the neuraxis of mammals. Boll. Soc. Ital. Biol. Sper. 40 24 (1964) 2136-2138
13. Dinocourt C., Petanjek Z., Freund T.F., Ben-Ari Y., and Esclapez M. Loss of interneurons innervating pyramidal cell dendrites and axon initial segments in the CA1 region of the hippocampus following pilocarpine-induced seizures. J. Comp. Neurol. 459 4 (2003) 407-425
14. Ekdahl C.T., Zhu C., Bonde S., Bahr B.A., Blomgren K., and Lindvall O. Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival. Neurobiol. Dis. 14 3 (2003) 513-523
15. Flajolet M., Rakhilin S., Wang H., Starkova N., Nuangchamnong N., Nairn A.C., and Greengard P. Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3. Proc. Natl. Acad. Sci. U. S. A. 100 26 (2003) 16006-16011
16. Freund T.F., and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6 4 (1996) 347-470
17. Fujikawa D.G. Neuronal death in mesial temporal sclerosis: separating morphology from mechanism. Epilepsia 44 12 (2003) 1607-1608 (1607; author reply)
18. Fujikawa D.G., Shinmei S.S., and Cai B. Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms. Epilepsia 41 Suppl. 6 (2000) S9-S13
19. Gehl L.M., Saab O.H., Bzdega T., Wroblewska B., and Neale J.H. Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia. J. Neurochem. 90 4 (2004) 989-997
20. Gorter J.A., Pereira P.M., van Vliet E.A., Aronica E., Lopes da Silva F.H., and Lucassen P.J. Neuronal cell death in a rat model for mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures. Epilepsia 44 5 (2003) 647-658
21. Greber S., Schwarzer C., and Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113 3 (1994) 737-740
22. Hendry S.H., Jones E.G., DeFelipe J., Schmechel D., Brandon C., and Emson P.C. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc. Natl. Acad. Sci. U. S. A. 81 20 (1984) 6526-6530
23. Jackson P.F., and Slusher B.S. Design of NAALADase inhibitors: a novel neuroprotective strategy. Curr. Med. Chem. 8 8 (2001) 949-957
24. Kamiya H., Shinozaki H., and Yamamoto C. Activation of metabotropic glutamate receptor type 2/3 suppresses transmission at rat hippocampal mossy fibre synapses. J. Physiol. 493 Pt 2 (1996) 447-455
25. Klapstein G.J., and Colmers W.F. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 3 1 (1993) 103-111
26. Leite J.P., Bortolotto Z.A., and Cavalheiro E.A. Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci. Biobehav. Rev. 14 4 (1990) 511-517
27. Lemos T., and Cavalheiro E.A. Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp. Brain Res. 102 3 (1995) 423-428
28. Lemos T., and Cavalheiro E.A. Status epilepticus and the late development of spontaneous seizures in the pilocarpine model of epilepsy. Epilepsy Res., Suppl. 12 (1996) 137-144
29. Meyerhoff J.L., Carter R.E., Yourick D.L., Slusher B.S., and Coyle J.T. Activity of a NAAG-hydrolyzing enzyme in brain may affect seizure susceptibility in genetically epilepsy-prone rats. Epilepsy Res., Suppl. 9 (1992) 163-172
30. Meyerhoff J.L., Carter R.E., Yourick D.L., Slusher B.S., and Coyle J.T. Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate. Brain Res. 593 1 (1992) 140-143
31. Miyamoto E. Study on N-acetyl-alpha-aspartylglutamic acid: I. Its purification and identification from the bovine brain. Seikagaku 39 1 (1967) 18-22
32. Moffett J.R. Reductions in N-acetylaspartylglutamate and the 67 kDa form of glutamic acid decarboxylase immunoreactivities in the visual system of albino and pigmented rats after optic nerve transections. J. Comp. Neurol. 458 3 (2003) 221-239
33. Moffett J.R., Namboodiri M.A., Cangro C.B., and Neale J.H. Immunohistochemical localization of N-acetylaspartate in rat brain. NeuroReport 2 3 (1991) 131-134
34. Moffett J.R., Namboodiri M.A., and Neale J.H. Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J. Histochem. Cytochem. 41 4 (1993) 559-570
35. Moffett J.R., and Namboodiri M.A. Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. J Neurocytol. 24 6 (1995) 409-433
36. Moffett J.R., and Namboodiri A.M. Expression of N-acetylaspartate and N-acetylaspartylglutamate in the nervous system. Adv Exp Med Biol. 576 (2006) 7-26
37. Neale J.H., Bzdega T., and Wroblewska B. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75 2 (2000) 443-452
38. Neema M., Navarro-Quiroga I., Chechlacz M., Gilliams-Francis K., Liu J., Lamonica K., Lin S.L., and Naegele J.R. DNA damage and nonhomologous end joining in excitotoxicity: neuroprotective role of DNA-PKCs in kainic acid-induced seizures. Hippocampus 15 8 (2005) 1057-1071
39. Pacheco Otalora L.F., Couoh J., Shigamoto R., Zarei M.M., and Garrido Sanabria E.R. Abnormal mGluR2/3 expression in the perforant path termination zones and mossy fibers of chronically epileptic rats. Brain Res. 1098 1 (2006) 170-185
40. Passani L.A., Vonsattel J.P., Carter R.E., and Coyle J.T. N-Acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases. Mol. Chem. Neuropathol. 31 2 (1997) 97-118
41. Passani L.A., Vonsattel J.P., and Coyle J.T. Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease. Brain Res. 772 1-2 (1997) 9-22
42. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (2004), Elsevier, New York
43. Poschel B., Wroblewska B., Heinemann U., and Manahan-Vaughan D. The metabotropic glutamate receptor mGluR3 is critically required for hippocampal long-term depression and modulates long-term potentiation in the dentate gyrus of freely moving rats. Cereb. Cortex 15 9 (2005) 1414-1423
44. 3H]norepinephrine release from rat hippocampal slices. J. Pharmacol. Exp. Ther. 266 2 (1993) 796-803
45. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin. Neurophysiol. 32 3 (1972) 281-294
46. Renno W.M., Lee J.H., and Beitz A.J. Light and electron microscopic immunohistochemical localization of N-acetylaspartylglutamate (NAAG) in the olivocerebellar pathway of the rat. Synapse 26 2 (1997) 140-154
47. Sanabria E.R., Wozniak K.M., Slusher B.S., and Keller A. GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism. J. Neurophysiol. 91 1 (2004) 182-193
48. Sayin U., Osting S., Hagen J., Rutecki P., and Sutula T. Spontaneous seizures and loss of axo-axonic and axo-somatic inhibition induced by repeated brief seizures in kindled rats. J. Neurosci. 23 7 (2003) 2759-2768
49. 3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain. Neurochem. Int. 38 1 (2001) 53-62
50. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235 4784 (1987) 73-76
51. Slusher B.S., Tsai G., Yoo G., and Coyle J.T. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J. Comp. Neurol. 315 2 (1992) 217-229
52. Sperk G., Bellmann R., Gruber B., Greber S., Marksteiner J., Roder C., and Rupp E. Neuropeptide Y expression in animal models of temporal lobe epilepsy. Epilepsy Res., Suppl. 12 (1996) 197-203
53. Swann J.W., Al-Noori S., Jiang M., and Lee C.L. Spine loss and other dendritic abnormalities in epilepsy. Hippocampus. 10 5 (2000) 617-625
54. Takeuchi H., Mizuno T., Zhang G., Wang J., Kawanokuchi J., Kuno R., and Suzumura A. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 280 11 (2005) 10444-10454
55. Treiman D.M. GABAergic mechanisms in epilepsy. Epilepsia 42 Suppl. 3 (2001) 8-12
56. Tsai G., Slusher B.S., Sim L., and Coyle J.T. Immunocytochemical distribution of N-acetylaspartylglutamate in the rat forebrain and glutamatergic pathways. J. Chem. Neuroanat. 6 5 (1993) 277-292
57. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., and Coyle J.T. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch. Gen. Psychiatry 52 10 (1995) 829-836
58. 13C]glucose. Neurosci. Lett. 251 3 (1998) 181-184
59. Uysal H., Cevik I.U., Soylemezoglu F., Elibol B., Ozdemir Y.G., Evrenkaya T., Saygi S., and Dalkara T. Is the cell death in mesial temporal sclerosis apoptotic?. Epilepsia 44 6 (2003) 778-784
60. van Vliet E.A., Aronica E., Tolner E.A., Lopes da Silva F.H., and Gorter J.A. Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation. Exp Neurol. 187 2 (2004) 367-379
61. Vornov J.J., Wozniak K., Lu M., Jackson P., Tsukamoto T., Wang E., and Slusher B. Blockade of NAALADase: a novel neuroprotective strategy based on limiting glutamate and elevating NAAG. Ann. N. Y. Acad. Sci. 890 (1999) 400-405
62. Westbrook G.L., Mayer M.L., Namboodiri M.A., and Neale J.H. High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture. J Neurosci. 6 11 (1986) 3385-3392
63. Williamson L.C., Eagles D.A., Brady M.J., Moffett J.R., Namboodiri M.A., and Neale J.H. Localization and synaptic release of N-acetylaspartylglutamate in the chick retina and optic tectum. Eur. J. Neurosci. 3 5 (1991) 441-451
64. Williams A.J., Lu X.M., Slusher B., and Tortella F.C. Electroencephalogram analysis and neuroprotective profile of the N-acetylated-alpha-linked acidic dipeptidase inhibitor, GPI5232, in normal and brain-injured rats. J. Pharmacol. Exp. Ther. 299 1 (2001) 48-57
65. Witkin J.M., Gasior M., Schad C., Zapata A., Shippenberg T., Hartman T., and Slusher B.S. NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Neuropharmacology 43 3 (2002) 348-356
66. Wolf N.I., Willemsen M.A., Engelke U.F., van der Knaap M.S., Pouwels P.J., Harting I., Zschocke J., Sistermans E.A., Rating D., and Wevers R.A. Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. Neurology 62 9 (2004) 1503-1508
67. Wroblewska B., Wroblewski J.T., Pshenichkin S., Surin A., Sullivan S.E., and Neale J.H. N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 69 1 (1997) 174-181
68. Wroblewska B., Wegorzewska I.N., Bzdega T., Olszewski R.T., and Neale J.H. Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes. J Neurochem. 96 4 (2006) 1071-1077
69. Xi Z.X., Baker D.A., Shen H., Carson D.S., and Kalivas P.W. Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. J Pharmacol Exp Ther. 300 1 (2002) 162-171
70. Zhao J., Ramadan E., Cappiello M., Wroblewska B., Bzdega T., and Neale J.H. NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and l-type calcium conductance. Eur J. Neurosci. 13 2 (2001) 340-346
71. Zhong C., Zhao X., Van K.C., Bzdega T., Smyth A., Zhou J., Kozikowski A.P., Jiang J., O'Connor W.T., Berman R.F., Neale J.H., and Lyeth B.G. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat. J. Neurochem. 97 4 (2006) 1015-1025 (May)
72. Zhou J., Neale J.H., Pomper M.G., and Kozikowski A.P. NAAG peptidase inhibitors and their potential for diagnosis and therapy. Nat. Rev., Drug Discov. 4 12 (2005) 1015-1026